Cobo Marc sold 78 shares of BridgeBio Oncology Therapeutics, Inc. at $2.37 for −$185 on Nov 13, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Principal Accounting Officer
Principal Accounting Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$184.86Shares × reported price
Shares traded
78Common Stock
Price per share
$2.37Reported price. Read footnotes for ranges.
% of reported position traded
0.56%This security and ownership context
Holdings after
13,734Direct
Trade date
Nov 13, 2026Sell
Filed
Nov 17, 2026, 4:35 PM ET4-day reporting delay
Accession
0001193125-26-465625Code S · Transaction 403610
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 13,812 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

BBOT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BBOT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +49%1w ago +5.2%1d ago +21%
Returns since7d30d90d180d1y

Footnotes in full

F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 24, 2026.